Mary Dillhoff

444 total citations
21 papers, 191 citations indexed

About

Mary Dillhoff is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Mary Dillhoff has authored 21 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Mary Dillhoff's work include Pancreatic and Hepatic Oncology Research (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Mary Dillhoff is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Mary Dillhoff collaborates with scholars based in United States and Brazil. Mary Dillhoff's co-authors include Timothy M. Pawlik, Jordan M. Cloyd, Carl Schmidt, Malcolm H. Squires, Aslam Ejaz, Sharon M. Weber, Amir A. Rahnemai‐Azar, Emily R. Winslow, Yutaka Endo and Zorays Moazzam and has published in prestigious journals such as Gastroenterology, International Journal of Radiation Oncology*Biology*Physics and The American Journal of Surgery.

In The Last Decade

Mary Dillhoff

19 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Dillhoff United States 8 96 90 72 59 50 21 191
Yazan Abboud United States 9 97 1.0× 125 1.4× 34 0.5× 43 0.7× 65 1.3× 60 281
Patrick Bou‐Samra United States 10 115 1.2× 115 1.3× 44 0.6× 75 1.3× 45 0.9× 28 285
S. Park South Korea 7 88 0.9× 154 1.7× 35 0.5× 98 1.7× 78 1.6× 20 311
Noah Cohen United States 9 51 0.5× 60 0.7× 32 0.4× 32 0.5× 35 0.7× 20 191
Timothy M. Pawlik United States 7 81 0.8× 70 0.8× 37 0.5× 57 1.0× 17 0.3× 31 161
Helga Hagman Sweden 7 55 0.6× 123 1.4× 36 0.5× 115 1.9× 7 0.1× 11 275
Hashem El‐Serag United States 4 27 0.3× 125 1.4× 104 1.4× 37 0.6× 102 2.0× 4 289
R Clifford United Kingdom 10 150 1.6× 184 2.0× 17 0.2× 55 0.9× 27 0.5× 26 312
M.-A. Allard France 6 66 0.7× 65 0.7× 92 1.3× 28 0.5× 18 0.4× 11 154
Mohamedraed Elshami United States 10 72 0.8× 169 1.9× 13 0.2× 49 0.8× 24 0.5× 49 237

Countries citing papers authored by Mary Dillhoff

Since Specialization
Citations

This map shows the geographic impact of Mary Dillhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Dillhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Dillhoff more than expected).

Fields of papers citing papers by Mary Dillhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Dillhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Dillhoff. The network helps show where Mary Dillhoff may publish in the future.

Co-authorship network of co-authors of Mary Dillhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Dillhoff. A scholar is included among the top collaborators of Mary Dillhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Dillhoff. Mary Dillhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsilimigras, Diamantis I., Selamawit Woldesenbet, Dimitrios Moris, et al.. (2025). Piperacillin-tazobactam versus cefoxitin as perioperative prophylaxis for pancreatoduodenectomy: real world evidence from the EPIC Cosmos database. HPB. 28(1). 70–77.
2.
Khan, Muhammad Muntazir Mehdi, Muhammad Musaab Munir, Yutaka Endo, et al.. (2024). Association of county‐level provider density with hepatobiliary cancer incidence and mortality. World Journal of Surgery. 48(9). 2243–2252. 1 indexed citations
3.
Baechle, Jordan J., Paula Marincola Smith, Mary Dillhoff, et al.. (2024). Survival disparities in rural versus urban patients with pancreatic neuroendocrine tumor: A multi-institutional study from the US neuroendocrine tumor study group. The American Journal of Surgery. 233. 125–131.
4.
Palettas, Marilly, et al.. (2024). The Association Between Patient-Reported Outcomes and Surgical Attrition During Neoadjuvant Therapy for Gastrointestinal Malignancies. Journal of Gastrointestinal Cancer. 56(1). 31–31. 1 indexed citations
5.
Moazzam, Zorays, Aslam Ejaz, Jordan M. Cloyd, et al.. (2023). The impact of digital inequities on gastrointestinal cancer disparities in the United States. Journal of Surgical Oncology. 128(1). 155–166. 7 indexed citations
6.
Ruff, Samantha M. & Mary Dillhoff. (2023). Review of IDH mutations and potential therapies for intrahepatic cholangiocarcinoma. Hepatoma Research. 1 indexed citations
7.
Khalil, Mujtaba, Diamantis I. Tsilimigras, Yutaka Endo, et al.. (2023). Association of Textbook Outcome and Hospital Volume with Long-Term Survival Following Resection for Hepatocellular Carcinoma: What Matters More?. Journal of Gastrointestinal Surgery. 27(12). 2763–2770. 16 indexed citations
8.
Ruff, Samantha M., Aslam Ejaz, Mary Dillhoff, et al.. (2023). Evaluating the caregiver experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology. 129(4). 775–784. 3 indexed citations
9.
Ruff, Samantha M., Ashish Manne, Jordan M. Cloyd, et al.. (2023). Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. Current Oncology. 30(6). 5863–5875. 12 indexed citations
10.
Lima, Henrique A., Yutaka Endo, Zorays Moazzam, et al.. (2023). The Impact of Medicaid Expansion on Early-Stage Hepatocellular Carcinoma Care. Annals of Surgical Oncology. 30(8). 4589–4599. 2 indexed citations
11.
Munir, Muhammad Musaab, Selamawit Woldesenbet, Muhammad Muntazir Mehdi Khan, et al.. (2023). Association between social determinants of health and delayed postoperative adjuvant therapy among patients undergoing resection of pancreatic cancer. Journal of Surgical Oncology. 129(5). 850–859. 16 indexed citations
12.
Dillhoff, Mary & Timothy M. Pawlik. (2021). Role of Node Dissection in Pancreatic Tumor Resection. Annals of Surgical Oncology. 28(4). 2374–2381. 9 indexed citations
13.
Krishna, Somashekar G., Phil A. Hart, Georgios I. Papachristou, et al.. (2021). Sa300 TANDEM EUS-GUIDED FINE NEEDLE INJECTION OF INTRACYSTIC SUBMICRON PARTICLE PACLITAXEL (NANOPAC®) AS TREATMENT FOR BRANCH-DUCT IPMN: AN INTERIM SAFETY, PHARMACOKINETIC, AND EFFICACY ANALYSIS. Gastroenterology. 160(6). S–475. 1 indexed citations
14.
Pawlik, Timothy M., Jordan M. Cloyd, & Mary Dillhoff. (2019). Intrahepatic Cholangiocarcinoma. 3 indexed citations
15.
Krishna, Somashekar G., Ahmad Malli, Samer El-Dika, et al.. (2018). 156 - A Large Single Center Experience using EUS-Guided Needle Based Confocal Laser Endomicroscopy for the Management of Pancreatic Cystic Lesions. Gastroenterology. 154(6). S–43. 1 indexed citations
16.
Squires, Malcolm H., Jordan M. Cloyd, Mary Dillhoff, Carl Schmidt, & Timothy M. Pawlik. (2018). Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology. 12(7). 671–681. 43 indexed citations
17.
Pandey, Pallavi, Ankur Pandey, Mary Dillhoff, et al.. (2017). Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy. Journal of Gastrointestinal Surgery. 22(2). 344–360. 3 indexed citations
18.
Rahnemai‐Azar, Amir A., Jordan M. Cloyd, Sharon M. Weber, et al.. (2017). Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency. Journal of Clinical and Translational Hepatology. 6(1). 1–8. 54 indexed citations
19.
Beal, Eliza W., Jeffery Chakedis, A. James Hanje, et al.. (2017). Interval Magnetic Resonance Imaging: an Alternative to Guidelines for Indeterminate Nodules Discovered in the Cirrhotic Liver. Journal of Gastrointestinal Surgery. 21(9). 1463–1470. 1 indexed citations
20.
Lu, Lanchun, et al.. (2016). Endoscopic 3-Dimensional OCT-Guided Brachytherapy for Early-Stage Pancreatic Cancers. International Journal of Radiation Oncology*Biology*Physics. 96(2). S167–S168. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yazan Abboud Breakdown of academic impact, for papers by Patrick Bou‐Samra Breakdown of academic impact, for papers by S. Park Breakdown of academic impact, for papers by Noah Cohen Breakdown of academic impact, for papers by Timothy M. Pawlik Breakdown of academic impact, for papers by Helga Hagman Breakdown of academic impact, for papers by Hashem El‐Serag Breakdown of academic impact, for papers by R Clifford Breakdown of academic impact, for papers by M.-A. Allard Breakdown of academic impact, for papers by Mohamedraed Elshami
Rankless by CCL
2026